4 April 2017
A brand new eye care service for Enfield residents will provide patients with top quality care closer to their homes.
From 1 April 2017 The Royal Free London and North Middlesex University Hospital will jointly provide the community ophthalmology service, which will be run by a range of healthcare professionals, including consultants, nurse specialists, orthoptists and optometrists.
The service is for adults and children with non-urgent conditions such as glaucoma, cataract care, macular degeneration, and blurred vision.
Patients will be seen at the following locations:
Chase Farm Hospital
127 The Ridgeway, Enfield,
Tel: 020 3758 2038
North Middlesex University Hospital
Sterling Way, London,
Tel: 020 8887 3935
Patients can access the service via a GP referral and will be offered a choice of clinic locations.
The service is a one-stop shop for patients who have routine clinical conditions.
The service is only for patients registered with an Enfield GP and is not for patients who need emergency care.
Martin Harris, the clinical lead for the service, said: “We are delighted to offer this new service for Enfield patients with routine eye conditions. This service will allow patients to access eye care closer to their homes in a one-stop shop. It will be staffed by a range of healthcare professionals offering patients high quality care and support.”
Image: A member of the ophthalmology team with a patient
Notes to editors
About the Royal Free London NHS Foundation Trust
The Royal Free began as a pioneering organisation and continues to play a leading role in the care of patients. Our mission is to provide world class expertise and local care. In the 21st century, the Royal Free London continues to lead improvements in healthcare.
The Royal Free London attracts patients from across the country and beyond to its specialist services in liver and kidney transplantation, haemophilia, renal care, HIV, infectious diseases, plastic surgery, immunology, Parkinson's disease, vascular surgery, cardiology, amyloidosis and scleroderma and we are a member of the academic health science partnership UCLPartners.